Stay updated on Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.

Latest updates to the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a new Revision: v3.7.0 entry to the study record history, indicating a new version of the record has been posted. The previous Revision: v3.6.6 entry was removed from the history table.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry v3.6.6 has been added to the record history, replacing the previous v3.6.5 entry. This reflects an update to the page’s versioning rather than changes to the trial data.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry, v3.6.5, was added to the record history, superseding the previous v3.6.4. This reflects a metadata update to the study record rather than changes to study data or eligibility.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page’s revision entry was updated from v3.6.3 to v3.6.4 in the record history, indicating a new version of the page has been stored for the study record. This reflects an internal update to the page rather than changes to study data or descriptions.SummaryDifference0.1%

- Check105 days agoChange DetectedRevision label updated to v3.6.3 in the page history, indicating a platform update rather than changes to study data.SummaryDifference0.1%

Stay in the know with updates to Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.